IndraLab

Statements

USP35 leads to the deubiquitination of ESR. 1 / 1

| 1

reach

"Moreover, AKT-activated USP35 enhanced ERα stability by interacting and deubiquitinating ERα, suggesting that USP35 may be a therapeutical vulnerability for ER breast cancer with endocrine resistance [21]."

36357379

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP35 leads to the deubiquitination of ESR. 1 / 1

INDRA sources:

Databases

Reading